Active transport can significantly impact drug toxicity by influencing drug concentrations in target tissues. For example, overexpression of efflux transporters can lead to reduced drug concentrations in therapeutic targets, necessitating higher doses that may increase toxicity. Conversely, a deficiency in these transporters can lead to drug accumulation and heightened adverse effects.
